Galectin-1, an alternative signal for T cell death, is increased in activated macrophages

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 5, 1999, Pages 557-567

  Rabinovich, G A ^a   Riera, C M ^a   Sotomayor, C E ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Apoptosis; Galectin 1; Immunomodulation; Macrophage

Indexed keywords

ANIMALIA;

GALECTIN 1; HEMAGGLUTININ;

ANIMAL; APOPTOSIS; CHEMISTRY; CYTOLOGY; EPITHELIUM CELL; HOMEOSTASIS; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEUKOCYTE; MACROPHAGE; METABOLISM; PHYSIOLOGY; REVIEW; T LYMPHOCYTE; THYMUS;

ANIMALS; APOPTOSIS; EPITHELIAL CELLS; GALECTIN 1; HEMAGGLUTININS; HOMEOSTASIS; IMMUNE SYSTEM; IMMUNE TOLERANCE; LEUKOCYTES; MACROPHAGES; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0033129603     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999000500009     Document Type: Article

References (67)

1. Barondes SH, Cooper DNW, Gitt MA & Leffler H (1994). Galectins: Structure and function of a large family of animal lectins. Journal of Biological Chemistry, 269: 20807-20810.
2. Barondes SH, Castronovo V, Cooper DNW, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K, Leffler H, Liu F, Lotan R, Mercurio AM, Monsigni M, Pillai S, Poirer F, Raz A, Rigby PWJ, Rini JM & Wang JL (1994). Galectins: a family of animal beta galactoside-binding lectins. Cell. 76: 597-598.
3. Moonjae C & Cummings RD (1997). Galectin-1: Oligomeric structure and interactions with polylactosamine. Trends in Glycoscience and Glycotechnology, 45: 47-56.
4. Cooper DNW (1997). Galectin-1: Secretion and modulation of cell interactions with lamimn. Trends in Glycoscience and Glycotechnology, 45: 57-67.
5. Wang JL, Laing JG & Anderson RL (1991). Lectin in the cell nucleus. Glycobiology, 1: 243-252.
6. Hirabayashi J & Kasai K (1993). The family of metazoan metal-independent ß-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology, 3: 297-304.
7. Barondes SH (1986). Vertebrate lectins: properties and functions. In: Lienner I, Sharon N & Goldstein I (Editors), The Lectins: Properties, Functions and Applications in Biology and Medicine, Academic Press, Orlando, FL, 447-465.
8. Kasai K & Hirabayashi J (1996). Galectins: a family of animal lectins that decipher glycocodes. Journal of Biochemistry, 119: 1-8.
9. Adams L, Kenneth Scott G & Weinberg CS (1996). Biphasic modulation of cell growth by recombinant human galectin-1. Biochimica et Biophysica Acta, 1312: 137-144.
10. Hughes RC (1992). Lectins as cell adhesion molecules. Current Opinion in Structural Biology, 2: 687-692.
11. Raz A & Lotan R (1987). Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer and Metastasis Reviews, 6: 433-452.
12. Levi G, Tarrab-Hazdai R & Teichberg VI (1983). Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits. European Journal of Immunology, 13: 500-507.
13. Offner H, Celnik B, Bringman TS, Casentini-Borocz D, Nedwin GE & Vandenbark A (1990). Recombinant human-galactoside-binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 28: 177-184.
14. Singer GG, Carrera AC, Marshak-Rothstein A, Martínez-AC & Abbas AK (1994). Apoptosis, Fas and systemic autoimmunity: the MRL lpr/lpr model. Current Opinion in Immunology, 6: 913-920.
15. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins A & Nagata S (1992). Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature, 356: 314-317.
16. Perillo NL, Oittenbogaart CH, Nguyen JT & Baum LG (1997). Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. Journal of Experimental Medicine, 97: 1851-1859
17. Iglesias MM, Rabinovich GA, Ivanovic V, Sotomayor CE & Wolfenstein-Todel C (1998). Galectin-1 from ovine placenta: complete primary structure, physicochemical properties and implications in the T cell death. European Journal of Biochemistry, 252: 400-407.
18. Perillo NL, Pace KE, Seilhamer JJ & Baum LG (1995). Apoptosis of T cells mediated by galectin-1. Nature, 378: 736-739.
19. Rabinovich GA, Iglesias MM, Modesti NM, Castagna L, Wolfenstein-Todel C, Riera CM & Sotomayor CE (1998). Rat activated macrophages produce a galectin-1-like protein which induces apoptosis of T cells: Biochemical and functional characterization. Journal of Immunology, 160: 4831-4840.
20. Evan GI, Brown L, Whyte M & Harrington E (1995). Apoptosis and the cell cycle Current Opinion in Cell Biology, 7: 825-834
21. Grassilli E, Carcereri de Prati A, Monti D, Troiano L, Menegazzi M, Barbieri D, Franceschi C & Suzuki H (1992). Studies of the relationship between cell proliferation and cell death. II. Early gene expression during concanavalin A-induced proliferation or dexamethasone-mduced apoptosis of rat thymocytes. Biochemical and Biophysical Research Communications, 188: 1261-1266.
22. Hartwell LH & Kastan MB (1994). Cell cycle control and cancer Science, 266: 1821-1828.
23. Schwartzman RA & Cidlowski JA (1993). Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrine Reviews, 14: 133-151.
24. Steller H (1995). Mechanisms and genes of cellular suicide. Science, 267: 1445-1449
25. Thompson CB (1995). Apoptosis in the pathogenesis and treatment of disease. Science, 267: 1456-1462
26. Vaux DL, Haecker G & Strasser A (1994). An evolutionary perspective on apoptosis. Cell, 76: 777-779.
27. Raff MC (1992). Social controls on cell survival and cell death. Nature, 356: 397-400
28. Squier MKT, Sehnert AJ & Cohen JJ (1995). Apoptosis in leukocytes. Journal of Leukocyte Biology, 57, 2-10.
29. Cohen JJ, Duke RC, Fadok VA & Sellins KS (1992). Apoptosis and programmed cell death in immunity. Annual Review of Immunology, 10: 267-293.
30. Surh CD & Sprent J (1994). T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature, 372: 100-103.
31. Sprent J, Lo D, Gao EK & Ron Y (1988). T cell selection in the thymus. Immunological Reviews, 101: 172-190.
32. Wyllie AH (1980). Glucocorticoid induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 284, 555-556.
33. Vacchio MS, Papadopulous V & Ashwell JD (1994). Steroid production in the thymus, implications for thymocyte selection. Journal of Experimental Medicine, 179: 1835-1846.
34. King LB, Vacchio MS, Hunziker R, Margulies DH & Ashwell JD (1995). A targeted of glucocorticoid receptor anti-sense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity, 5: 647-656.
35. Takayama H & Sitkovskv MV (1989). Potential use of an antagonist of cAMP-dependent protein kinase to block inhibition and modulate T-cell receptor-triggered activation of cytotoxic T-lymphocytes. Journal of Pharmaceutical Sciences, 78: 8-10.
36. Iwata M, Mukai M, Nakai Y & Iseki R (1992). Retinoic acids inhibit activation-induced apoptosis in T cell hybridomas and thymocytes. Journal of Immunology, 149: 3302-3308.
37. Migliorati G, Nicoletti I, Pagliacci MC & Riccardi C (1992). Glucocorticoid-induced thymocyte apoptosis: inhibition by interleukin-2 and interleukin-4. Pharmacological Research, 25: 15-16.
38. Goldstone SD & Lavin MF (1991). Isolation of a cDNA clone, encoding a human-galactoside-binding protein overexpressed during glucocorticoid-induced cell death. Biochemical and Biophysical Research Communications, 178: 746-750.
39. Anderson G, Owen JJT, Moore NC & Jenkinson EJ (1994). Thymic epithelial cells provide unique signals for positive selection of CD4+CD8+ thymocytes in vitro. Journal of Experimental Medicine, 179: 2027-2031.
40. Anderson G, Moore NC, Owen JJT & Jenkinson EJ (1996). Cellular interactions in thymocyte development. Annual Review of Immunology, 14: 73-99.
41. Baum LG, Pang M, Perillo ML, Wu T, Delegeane A, Uittenbogaart CH, Fukuda M & Seilhamer JJ (1995). Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. Journal of Experimental Medicine, 181: 877-887.
42. Dhein J, Walczak H, Baumler C, Debatin KM & Kramer PH (1995). Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature, 373: 438-441.
43. Bruner T, Mogil RJ, LaFace D, Yoo NJ, Mahoubl A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF & Green DR (1995). Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature, 373: 441-444.
44. Ju S-T, Panka DJ, Cul H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ & Marsak-Rothstein A (1995). Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature, 373: 444-448.
45. Russell JH, Rush B, Weaver C & Wang R (1993). Mature T cells of autoimmune lpr/ lpr mice have a defect in antigen-stimulated suicide. Proceedings of the National Academy of Sciences, USA, 90: 4409-4413.
46. Russell JH & Wang R (1993). Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathway in activated mature T cells. European Journal of Immunology, 23: 2379-2382.
47. Adachi M, Suematsu S, Kondo T, Ogasawara J, Tanaka T, Yoshida N & Nagata S (1995). Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nature Genetics, 11: 294-300.
48. Adachi M, Suematsu S, Suda T, Watanabe D, Fukuyama H, Ogasawara J, Tanaka T, Yoshida N & Nagata S (1996). Enhanced and accelerated lymphoproliferation in Fas-null-mice. Proceedings of the National Academy of Sciences, USA, 93: 2131-2136.
49. Nishimura Y, Ishii A, Kobayashi Y, Yamasaki Y & Yonehara S (1995). Expression and function of mouse Fas antigen on immature and mature T cells. Journal of Immunology, 154: 4395-4403.
50. Tanaka M, Suda T, Takanahashi T & Nagata S (1995). Expression of the functional soluble forms of the human Fas ligand in activated lymphocytes. EMBO Journal, 14: 1129-1135.
51. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K & Nagata S (1995). Expression of the Fas ligand in cells of the T cell lineage. Journal of Immunology. 154: 3806-3813.
52. Osborne BA (1996). Apoptosis and the maintenance of homeostasis in the immune system. Current Opinion in Immunology, 8: 245-254.
53. Su ZZ, Lin J, Shen R, Fisher PE, Goldstein NI & Fisher PB (1996). Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1, a member of the galectin gene family. Proceedings of the National Academy of Sciences, USA, 93: 7252-7257.
54. Allen HJ, Sucato D, Gottstine S, Kisailus E, Nava H, Petrelli N, Castillo N & Wilson D (1991). Localisation of endogenous beta-galactoside-binding lectin in human cells and tissues. Tumor Biology, 12: 52-60.
55. Adams D & Hamilton TA (1984). The cell biology of macrophage activation. Annual Review of Immunology, 2: 283-318.
56. Rabinovich GA, Castagna LF, Landa CA, Riera CM & Sotomayor CE (1996). Regulated expression of a 16-kd galectin-like protein in activated rat macrophages. Journal of Leukocyte Biology, 59: 363-370.
57. Clerch LB, Whitney P, Mass M, Brew K, Miller T, Werner R & Massaro D (1988). Sequence of a full-length cDNA for rat lung ß-galactoside-binding protein: Primary and secondary structure of the lectin. Biochemistry, 27: 692-699.
58. Wilson TJG, Firth MN, Powell JT & Harrison FL (1989). The sequence of the mouse 14 kDa ß-galactoside-binding lectin and evidence for its synthesis on free cytoplasmic ribosomes. Biochemical Journal, 261: 847-852.
59. Abbott WM, Mellor A, Edwards Y & Feizi T (1989). Soluble bovine galactoside-binding lectin cDNA reveals the complete amino acid sequence and an antigenic relationship with the major encephalitogenic domain of myelin basic protein. Biochemical Journal, 259: 283-290.
60. Hirabayashi J & Kasai K (1988). Complete amino acid sequence of a ß-galactoside-binding lectin from human placenta. Journal of Biochemistry, 104: 1-4.
61. Bladier D, Le Caer JP, Joubert R, Caron M & Rossier J (1991). ß-galactoside soluble lectin from human brain: complete amino acid sequence. Neurochemistry International, 18: 275-283.
62. Beyer EC, Zweig SE & Barondes SH (1980). Two lactose-binding lectins from chicken tissues. Purified lectin from intestine is different from those in liver and muscle. Journal ol Biological Chemistry, 255: 4236-4239.
63. Yang RY, Hsu DK & Liu FT (1996). Expression of galectin-3 modulates T cell growth and apoptosis. Proceedings of the National Academy of Sciences, USA, 93: 6737-6742.
64. Kroemer G (1997). The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Medicine, 6: 614-620.
65. Rabinovich GA, Modesti N, Castagna LF, Landa C, Riera CM & Sotomayor CE (1997). Specific inhibition of lymphocyte proliferation and induction of apoptosis by CLL-I, a ß-galactoside-binding lectin. Journal of Biochemistry, 122: 365-373.
66. Poirrier F & Robertson EJ (1993). Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin. Development, 119: 1229-1236.
67. Leffler H (1997). Introduction to galectins. Trends in Glycoscience and Glycotechnology, 9: 9-19.